Quibim
PrivateLast Round
Series A
Jan 28, 2025
Total Funding Raised
$61.71M
Company Overview
Quibim operates in Healthcare & Life Sciences and is based in Valencia. Its latest recorded funding round was a Series A round in January 2025.
Quibim is a health technology company that develops artificial intelligence-powered solutions for medical imaging analysis to extract quantitative biomarkers for diagnostics and drug development.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quibim Comparables
Compare Quibim with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qure.ai | 82% | |
| Brainomix | 81% | |
| Cortechs.ai | 80% |
For institutional investors. Book with your work email.
Quibim Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 28, 2025 | ||||
| Seed | Jul 21, 2020 | ||||
| Grant | Dec 1, 2018 | ||||
| Grant | Feb 1, 2018 |
For institutional investors. Book with your work email.
Quibim Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series A |
| Amadeus Capital Partners | Series A, Seed |
| Partech | Seed, Series A |
| Partech | Series A |
| UI Investissement | Series A |
| Leadwind | Series A |
| GED Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2026
Grew 19% QoQ, from 93 to 111 employees.
- Nov 21, 2025
Unveiled new oncology platform at RSNA 2025.
For institutional investors. Book with your work email.
Quibim Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Quibim's valuation, stock price, and market status.
Is Quibim a public or private company?
Quibim is a private company.
What is the current stock price of Quibim?
Quibim is a private company, so its shares have no public market price. Caplight tracks Quibim's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Quibim worth (valuation)?
Valuation information for Quibim is not publicly available.
Can I buy Quibim stock?
Quibim shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Quibim's last funding round?
Quibim's most recent funding round was Series A on January 28, 2025.
Who are the main investors in Quibim?
Key investors in Quibim include Asabys Partners, Amadeus Capital Partners, GED Capital, Buenavista Equity Partners, Adara Ventures.
Will Quibim IPO soon?
No public IPO plans have been announced for Quibim.
How can I track Quibim secondary market activity?
Caplight tracks bids, offers, and trades in Quibim's shares on secondary markets.